Guangliang Li - Publications
Affiliations: | 2020- | Immunology | Tianjin Medical University, China |
Year | Citation | Score | |||
---|---|---|---|---|---|
2022 | Zhu H, Li G, Yin J, Zhang H, Da Y, Li L. Anlotinib attenuates experimental autoimmune encephalomyelitis mice model of multiple sclerosis modulating the differentiation of Th17 and Treg cells. Immunopharmacology and Immunotoxicology. 1-9. PMID 35638564 DOI: 10.1080/08923973.2022.2071722 | 0.547 | |||
2019 | Li H, Hong W, Jin X, Li G, Zhou G, Fan L. The aryl hydrocarbon receptor is a novel negative regulator of interleukin-17-mediated signaling and inflammation in vitro. Febs Letters. PMID 30953345 DOI: 10.1002/1873-3468.13380 | 0.457 | |||
2016 | Lu H, Li G, Zhou C, Jin W, Qian X, Wang Z, Pan H, Jin H, Wang X. Regulation and role of post-translational modifications of enhancer of zeste homologue 2 in cancer development. American Journal of Cancer Research. 6: 2737-2754. PMID 28042497 | 0.342 | |||
2012 | Chen Y, Duan Y, Kang Y, Yang X, Jiang M, Zhang L, Li G, Yin Z, Hu W, Dong P, Li X, Hajjar DP, Han J. Activation of liver X receptor induces macrophage interleukin-5 expression. The Journal of Biological Chemistry. 287: 43340-50. PMID 23150660 DOI: 10.1074/jbc.M112.403394 | 0.355 | |||
Show low-probability matches. |